5,6-BICYLIC HETEROARYL-CONTAINING UREA COMPOUNDS AS KINASE INHIBITORS

摘要

The present invention provides 5,6-bicyclic heteroaryl-containing urea compounds of Formula I or II and use of the same for treating conditions mediated by protein kinase such as VEGFR2, c-Met, PDGFRbeta c-Kit, CSF1R, or EphA2.